Participants were randomized to receive either asundexian (50 mg once daily) or apixaban (5 mg twice daily). Interim findings showed that asundexian led to fewer bleeding events; however ...

With the emergence and approval of other new oral anticoagulants such as dabigatran and rivaroxaban, the role of and place in therapy for all of these new agents will have to be clearly delineated.

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban ... about a discount of 40% to 60% of the branded price. Xarelto, along with Eliquis and Jardiance, ...

Treatment for atrial fibrillation was initiated, including rate control and anticoagulation with 5 mg of apixaban two times per day for primary stroke prophylaxis. Three days after initiation of ...

Patients will be randomized 1:1 to receiving apixaban 5 mg twice daily or warfarin with a target international normalized ratio of 2.0-3.0. The last randomized participant will be followed for at ...

2 Need for antithrombotic therapy after TAVR Patients undergoing TAVR have an increased risk of thrombotic and bleeding events in the periprocedural period and during long-term follow-up post TAVR ...

Differences between Asia and non-Asia were still present but smaller for apixaban (56.8% vs 75.4% received 10 mg daily, respectively) (table 3). Distribution of NOAC daily dose among GARFIELD-AF ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

I am 71, and I recently saw my urologist for urinating a lot and not getting enough sleep. He performed a flow test and a ...

HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating ...

It's reported more than 8 million Americans take a blood thinner. One has been recalled for potential absorption issues.